Arca
Skip to content

Renal insufficiency

Drug research and approvals for renal insufficiency: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 740 studies of renal insufficiency are recruiting on ClinicalTrials.gov, Health Canada has authorized 5 drug trials for it since 2013, and the EU has 4 authorised medicines for it.

  • Recruiting worldwide: 740
  • Trials authorized in Canada: 5
  • FDA orphan approvals: 0
  • EU medicines: 4

Recruiting Now

Newest start dates first, of 740 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

Newest first; search them all in Canada trials
Jan 23, 2019Pharmacokinetic of tobramycin administered at the beginning of an intermittent hemodialysis session (esrd study)TOBRAMYCINCENTRE INTEGRE UNIVERSITAIRE DE SANTE ET DE SERVICES SOCIAUX DE L'EST DE MONTREAOngoing
Dec 22, 2015Study of the bioaccumulation of tinzaparin in renally impaired patients when given at prophylactic dosesINNOHEPHOPITAL MAISONNEUVE ROSEMONTPending
May 22, 2013A phase I, multi-center, non-randomized, open label, parallel-group study evaluating the pharmacokinetics and safety of regorafenib (bay 73-4506) in cancer…REGORAFENIB (BAY 73-4506)BayerClosed
May 8, 2013"a phase IIIb open label study to optimize the single bolus dose of dalteparin sodium for the prevention of clotting within the extracorporeal system during…FRAGMIN (DALTEPARIN SODIUM)PfizerOngoing
Apr 12, 2013A phase II multi-center, parallel-group, randomized, double blind, proof-of-concept, adaptive study investigating the safety and efficacy of thr-184…THR-184THRASOS INNOVATION INCClosed

Medicines Authorised in the EU

Newest first
Apr 24, 2023VafseovadadustatMedice Arzneimittel Pütter GmbH & Co. KGEMA ↗
Feb 16, 2022KerendiafinerenoneBayer AGEMA ↗
May 27, 2015JinarctolvaptanOtsuka Pharmaceutical Netherlands B.V.EMA ↗
Feb 2, 2005Fendrixhepatitis B (rDNA) vaccine (adjuvanted, adsorbed)GlaxoSmithKline Biologicals S.A.EMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.